BRCA1 and ovarian serous adenocarcinoma: Similar findings have been reported in studies involving individuals with ovarian cancer, where patients with advanced high-grade serous ovarian cancer and BRCA1/2 mutations exhibited extended progression-free survival and higher overall survival rates [36].